HALEON UK FINANCE LIMITED
Get an alert when HALEON UK FINANCE LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-08-30 (in 3mo)
Last made up 2025-08-16
Watchouts
None on the register
Cash
£2B
+170.8% vs 2023
Net assets
£675M
+4.8% vs 2023
Employees
—
Average over period
Profit before tax
£42M
+62.5% vs 2023
Net assets
2-year trend · vs Financials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | — | — | |
| Profit before tax | £25,546,000 | £41,524,000 | |
| Net profit | £19,496,000 | £30,951,000 | |
| Cash | £679,079,000 | £1,838,789,000 | |
| Total assets less current liabilities | £858,245,000 | £744,768,000 | |
| Net assets | £643,613,000 | £674,564,000 | |
| Equity | £643,613,000 | £674,564,000 | |
| Average employees | — | — | |
| Wages | — | — | |
| Directors' remuneration | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
+170.8%
£679,079,000 £1,838,789,000
-
Net assets
+4.8%
£643,613,000 £674,564,000
-
Employees
—
Not reported
-
Profit before tax
+62.5%
£25,546,000 £41,524,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Gearing (liabilities / total assets) | 95.5% | 91.9% | |
| Current ratio | 0.74x | 1.06x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- HALEON UK FINANCE LIMITED 2023-04-14 → present
- GLAXOSMITHKLINE CONSUMER HEALTHCARE FINANCE LIMITED 2014-11-06 → 2023-04-14
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Having assessed the principal risks and considered other matters, the Directors are of the opinion that the current level. of activity remains is sustainable. In relation to the potential downside trading scenarios, the considerations have included the accessibility of additional capital and the potential risk to liquidity. The Directors have taken into account that as part of the Group, the Company has already received the necessary letter of support from Haleon Intermediate Holdings Limited as and can take actions to ensure business continuity through operational channels, as well as the ability to manage variable costs. On the basis of those considerations, the Directors believe that it remains appropriate to adopt the going concern basis of accounting in preparing the financial statements.”
Group structure
- HALEON UK FINANCE LIMITED · parent
- Haleon UK Capital PLC 100%
- Haleon Netherlands Capital B.V. 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 14 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HALEON UK CORPORATE SECRETARY LIMITED | Corporate Secretary | 2022-04-01 | — | — |
| MEHMOOD, Sajid | Director | 2022-03-04 | Jun 1977 | Pakistani |
| ROWE, Michael John | Director | 2022-03-04 | Apr 1969 | British |
| HALEON UK CORPORATE DIRECTOR LIMITED | Corporate Director | 2022-04-01 | — | — |
| HALEON UK CORPORATE SECRETARY LIMITED | Corporate Director | 2022-04-01 | — | — |
Show 14 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Secretary | 2014-11-06 | 2022-04-01 |
| ARISTIDOU, Antrinkos Andrew | Director | 2019-08-19 | 2020-03-10 |
| AROVAH, Hanief Ardiasyah Fadhol | Director | 2020-03-10 | 2021-06-18 |
| BLACKBURN, Paul Frederick | Director | 2014-11-06 | 2016-03-01 |
| BOX, Jonathan Wilson | Director | 2016-06-17 | 2017-11-30 |
| COOPER, Nicholas Ian | Director | 2019-09-11 | 2022-03-04 |
| FOSTER-HAWES, Melanie | Director | 2016-06-17 | 2019-01-15 |
| GODINO ESCOLAR, Mariano Jesus | Director | 2021-06-22 | 2022-03-04 |
| GREEN, Richard | Director | 2019-01-15 | 2020-03-10 |
| HESTLER, Tobias Hannes | Director | 2017-11-30 | 2020-03-10 |
| PROKOPCHUK, Eugene | Director | 2019-03-18 | 2020-03-10 |
| WALKER, Adam | Director | 2015-06-03 | 2016-08-01 |
| EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Director | 2014-11-06 | 2022-04-01 |
| GLAXO GROUP LIMITED | Corporate Director | 2014-11-06 | 2022-04-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Haleon Uk Enterprises Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-12-13 | Active |
| Consumer Healthcare Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-07-02 | Ceased 2019-12-13 |
| Glaxosmithkline Consumer Healthcare Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2019-07-02 |
Filing timeline
Last 20 of 84 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-02-26 RESOLUTIONS Resolution
- 2025-02-26 MA Memorandum articles
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-09-25 | CH01 | officers | Change person director company with change date | |
| 2025-08-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-08-05 | CH01 | officers | Change person director company with change date | |
| 2025-08-05 | CH01 | officers | Change person director company with change date | |
| 2025-07-21 | AA | accounts | Accounts with accounts type full | |
| 2025-02-26 | RESOLUTIONS | resolution | Resolution | |
| 2025-02-26 | MA | incorporation | Memorandum articles | |
| 2024-08-24 | AA | accounts | Accounts with accounts type full | |
| 2024-08-16 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-05-31 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-05-31 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-11-03 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-08-15 | AA | accounts | Accounts with accounts type full | |
| 2023-06-05 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-06-05 | CH02 | officers | Change corporate director company with change date | |
| 2023-06-05 | CH02 | officers | Change corporate director company with change date | |
| 2023-06-05 | CH04 | officers | Change corporate secretary company with change date | |
| 2023-05-25 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-05-19 | CH04 | officers | Change corporate secretary company with change date | |
| 2023-05-19 | CH02 | officers | Change corporate director company with change date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.